Profil
Debra Segal is currently the Head of Regulatory Affairs at Dianthus Therapeutics, Inc. Prior to her current position, she served as the Senior Vice President of Regulatory Affairs at Scholar Rock, Inc. from 2021 to 2023.
Postes actifs de Debra Segal
| Sociétés | Poste | Début |
|---|---|---|
| DIANTHUS THERAPEUTICS, INC. | Conseiller Juridique Général | 11/09/2023 |
Anciens postes connus de Debra Segal
| Sociétés | Poste | Fin |
|---|---|---|
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Conseiller Juridique Général | 01/03/2023 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DIANTHUS THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Scholar Rock, Inc.
Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Health Technology |